Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSN357AB multiple-dose trial in type 2 diabetes
2005-004337-18Phase 2Completed
- Sponsor
- OSI Pharmaceuticals
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing PSN357AB with Placebo (2 arms). Primary endpoints: Pharmacodynamic endpoints, Safety and tolerability and 1 more. Started Sep 2005; status: completed.
02
Drugs
PSN-357
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-004337-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004337-18.